Dominik Emmerdinger
The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease
Storr M, Emmerdinger D, Diegelmann J, Pfennig S, Ochsenkühn T, Göke B, Lohse P, Brand S. The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease. PloS one 2010; 5:e9453.
26.02.2010The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease
26.02.2010PloS one 2010; 5:e9453
Storr Martin, Emmerdinger Dominik, Diegelmann Julia, Pfennig Simone, Ochsenkühn Thomas, Göke Burkhard, Lohse Peter, Brand Stephan
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors
Storr M, Patel K, Brand S, Göke B, Lutz B, Buckley N, Massa F, Sibaev A, Yüce B, Zhang H, Emmerdinger D, Keenan C, Sharkey K. Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors. J Mol Med 2008; 86:925-36.
21.05.2008Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors
21.05.2008J Mol Med 2008; 86:925-36
Storr Martin A, Patel Kamala D, Brand Stephan, Göke Burkhard, Lutz Beat, Buckley Nancy E, Massa Federico, Sibaev Andrei, Yüce Birol, Zhang Hong, Emmerdinger Dominik, Keenan Catherine M, Sharkey Keith A